SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-19-022474
Filing Date
2019-06-13
Accepted
2019-06-13 17:06:30
Documents
6
Effectiveness Date
2019-06-13

Document Format Files

Seq Description Document Type Size
1 S-8 reta-s8.htm S-8 82653
2 EX-4.5 reta-ex45_68.htm EX-4.5 20792
3 EX-5.1 reta-ex51_7.htm EX-5.1 11962
4 EX-23.2 reta-ex232_6.htm EX-23.2 2757
5 GRAPHIC gdry5pyo2sjm000001.jpg GRAPHIC 4496
6 GRAPHIC gdry5pyo2sjm000002.jpg GRAPHIC 1840
  Complete submission text file 0001564590-19-022474.txt   128185
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-232099 | Film No.: 19896789
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences